Morphine Versus Midazolam as Upfront Therapy to Control Dyspnea Perception in Cancer Patients While Its Underlying Cause Is Sought or Treated

Journal of Pain and Symptom Management

Volumn 39, Issue 5, 2010, Pages 820-830

  Navigante, Alfredo H ^a   Castro, Monica A ^a   Cerchietti, Leandro C ^a,b  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

benzodiazepines; cancer; Dyspnea; midazolam; morphine; opioids

Indexed keywords

MIDAZOLAM; MORPHINE;

ADULT; ADVANCED CANCER; AGED; AGITATION; AMBULATORY CARE; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DYSPNEA; FLUSHING; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; DRUG ADMINISTRATION SCHEDULE; DYSPNEA; FEMALE; HUMANS; MALE; MIDAZOLAM; MIDDLE AGED; MORPHINE; NEOPLASMS; PATIENT SELECTION; PERCEPTION; TREATMENT OUTCOME;

EID: 77952299580     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.10.003     Document Type: Article

References (23)

1. Stromgren A.S., Sjogren P., Goldschmidt D., et al. Symptom priority and course of symptomatology in specialized palliative care. J Pain Symptom Manage 31 (2006) 199-206
2. Ferreira K.A., Kimura M., Teixeira M.J., et al. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage 35 (2008) 604-616
3. von Leupoldt A., and Dahme B. Cortical substrates for the perception of dyspnea. Chest 128 (2005) 345-354
4. Evans K.C., Banzett R.B., Adams L., et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 88 (2002) 1500-1511
5. Brannan S., Liotti M., Egan G., et al. Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air. Proc Natl Acad Sci U S A 98 (2001) 2029-2034
6. Liotti M., Brannan S., Egan G., et al. Brain responses associated with consciousness of breathlessness (air hunger). Proc Natl Acad Sci U S A 98 (2001) 2035-2040
7. Parsons L.M., Egan G., Liotti M., et al. Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air. Proc Natl Acad Sci U S A 98 (2001) 2041-2046
8. Oertel B.G., Preibisch C., Wallenhorst T., et al. Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther 83 (2008) 577-588
9. Leppa M., Korvenoja A., Carlson S., et al. Acute opioid effects on human brain as revealed by functional magnetic resonance imaging. Neuroimage 31 (2006) 661-669
10. Paulus M.P., Feinstein J.S., Castillo G., Simmons A.N., and Stein M.B. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry 62 (2005) 282-288
11. Wise R.G., Lujan B.J., Schweinhardt P., et al. The anxiolytic effects of midazolam during anticipation to pain revealed using fMRI. Magn Reson Imaging 25 (2007) 801-810
12. Thomas J.R., and von Gunten C.F. Clinical management of dyspnoea. Lancet Oncol 3 (2002) 223-228
13. Ben-Aharon I., Gafter-Gvili A., Paul M., Leibovici L., and Stemmer S.M. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 26 (2008) 2396-2404
14. Currow D.C., and Abernethy A.P. Pharmacological management of dyspnoea. Curr Opin Support Palliat Care 1 (2007) 96-101
15. Viola R., Kiteley C., Lloyd N.S., et al., Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 16 (2008) 329-337
16. Wiffen P.J., and McQuay H.J. Oral morphine for cancer pain. Cochrane Database Syst Rev 4 (2007) CD003868
17. Dy S.M., Asch S.M., Naeim A., et al. Evidence-based standards for cancer pain management. J Clin Oncol 26 (2008) 3879-3885
18. Booth S., Moosavi S.H., and Higginson I.J. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nat Clin Pract Oncol 5 (2008) 90-100
19. Navigante A.H., Cerchietti L.C., Castro M.A., Lutteral M.A., and Cabalar M.E. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 31 (2006) 38-47
20. Lugo R.A., and Kern S.E. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother 16 (2002) 5-18
21. Nordt S.P., and Clark R.F. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 15 (1997) 357-365
22. Dorman S., Byrne A., and Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 21 (2007) 177-191
23. Jennings A.L., Davies A.N., Higgins J.P., and Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev 4 (2001) CD002066